![Janet E. Buhlmann](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Janet E. Buhlmann
Keine laufenden Positionen mehr
Profil
Dr. Janet E.
Buhlmann is a Director-Molecular Immunology at EpiVax, Inc.
She received her undergraduate degree from Mount Holyoke College and a doctorate degree from Dartmouth College.
Ehemalige bekannte Positionen von Janet E. Buhlmann
Unternehmen | Position | Ende |
---|---|---|
EpiVax, Inc.
![]() EpiVax, Inc. Pharmaceuticals: OtherHealth Technology EpiVax, Inc. provides reengineering therapeutic proteins and design new vaccines. Its services include immunogenicity screening, immunogenicity testing, protein engineering and vaccine design and redesign. The company was founded by Anne S. De Groot in 1998 and is headquartered in Providence, RI. | Corporate Officer/Principal | - |
Ausbildung von Janet E. Buhlmann
Mount Holyoke College | Undergraduate Degree |
Dartmouth College | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
EpiVax, Inc.
![]() EpiVax, Inc. Pharmaceuticals: OtherHealth Technology EpiVax, Inc. provides reengineering therapeutic proteins and design new vaccines. Its services include immunogenicity screening, immunogenicity testing, protein engineering and vaccine design and redesign. The company was founded by Anne S. De Groot in 1998 and is headquartered in Providence, RI. | Health Technology |